JMP Securities Starts AN2 Therapeutics (ANTX) at Market Outperform
Tweet Send to a Friend
JMP Securities analyst Roy Buchanan initiates coverage on AN2 Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
